首页> 外文期刊>Journal of Medicinal Chemistry >Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase II alpha-Targeted Chemotherapeutic Agents for Breast Cancer
【24h】

Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase II alpha-Targeted Chemotherapeutic Agents for Breast Cancer

机译:卤代的2,4-二苯基Indeno [1,2-B]吡啶酚衍生物的发现和生物学评价为乳腺癌有效的拓扑异构酶IIα靶向化学治疗剂

获取原文
获取原文并翻译 | 示例
           

摘要

With the aim of developing new effective topoisomerase II alpha-targeted anticancer agents, we synthesized a series of hydroxy- and halogenated 2,4-diphenyl indeno[1,2-b]pyridinols using a microwave-assisted single step synthetic method and investigated structure-activity relationships. The majority of compounds with chlorophenyl group at 2-position and phenol group at the 4-position of indeno[1,2-b]pyridinols exhibited potent antiproliferative activity and topoisomerase H alpha-selective inhibition. Of the 172 compounds tested, 89 showed highly potent and selective topoisomerase H alpha inhibition and antiproliferative activity in the nanomolar range against human T47D breast (2.6 nM) cancer cell lines. In addition, mechanistic studies revealed compound 89 is a nonintercalative topoisomerase II poison, and in vitro studies showed it had promising cytotoxic effects in diverse breast cancer cell lines and was particularly effective at inducing apoptosis in T47D cells. Furthermore, in vivo administration of compound 89 had significant antitumor effects in orthotopic mouse model of breast cancer.
机译:目的是开发新的有效拓扑酶酶IIα靶向抗癌剂,我们使用微波辅助单步合成方法和研究结构合成一系列羟基和卤化2,4-二苯基IneNo [1,2-B]吡啶酚 - 行为关系。在Indeno [1,2-B]吡啶酚的4-位置处的2-位置和苯酚基的大部分化合物和苯酚基团表现出有效的抗增殖活性和拓扑异构酶Hα选择性抑制。在测试的172个化合物中,89显示出高效和选择性的拓扑异构酶Hα抑制和纳米摩尔范围内的抗抗溶剂活性,对人T47D乳腺(2.6nm)癌细胞系。此外,揭示了化合物89的机械研究是一种不含含有的膨胀性拓扑异构酶II毒药,并且在体外研究表明它在不同乳腺癌细胞系中具有有前途的细胞毒性作用,并且特别有效在T47D细胞中诱导细胞凋亡。此外,体内施用化合物89在乳腺癌的原位小鼠模型中具有显着的抗肿瘤作用。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2019年第17期|共41页
  • 作者单位

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Ewha Womans Univ Grad Sch Pharmaceut Sci Coll Pharm Seoul 120750 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Ewha Womans Univ Grad Sch Pharmaceut Sci Coll Pharm Seoul 120750 South Korea;

    Ewha Womans Univ Grad Sch Pharmaceut Sci Coll Pharm Seoul 120750 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Daegu Gyeongbuk Med Innovat Fdn Lab Anim Ctr Daegu 41061 South Korea;

    Daegu Gyeongbuk Med Innovat Fdn Lab Anim Ctr Daegu 41061 South Korea;

    Daegu Gyeongbuk Med Innovat Fdn Lab Anim Ctr Daegu 41061 South Korea;

    Daegu Gyeongbuk Med Innovat Fdn Lab Anim Ctr Daegu 41061 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

    Ewha Womans Univ Grad Sch Pharmaceut Sci Coll Pharm Seoul 120750 South Korea;

    Yeungnam Univ Coll Pharm Gyongsan 38541 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号